Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 6

Results: 5
    1
    2
    3

    Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.

    Published in:
    Medical Oncology, 2022, v. 39, n. 6, p. 1, doi. 10.1007/s12032-022-01700-4
    By:
    • Fey, Theres;
    • Erickson, Nicole;
    • Stahler, Arndt;
    • Muenchhoff, Maximilian;
    • Keppler, Oliver T.;
    • Ruehlmann, Katharina;
    • Krauss-Pfeiffer, Gabriele;
    • Steinberg, Hannah;
    • Graf, Alexander;
    • Krebs, Stefan;
    • Blum, Helmut;
    • Khatamzas, Elham;
    • Seynstahl, Sarah;
    • Casuscelli, Jozefina;
    • Markwardt, Daniel;
    • Forstpointner, Roswitha;
    • Schinköthe, Timo;
    • von Bergwelt-Baildon, Michael;
    • Heinemann, Volker
    Publication type:
    Article
    4

    Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer.

    Published in:
    Medical Oncology, 2022, v. 39, n. 6, p. 1, doi. 10.1007/s12032-022-01662-7
    By:
    • Reyes, Diane K.;
    • Trock, Bruce J.;
    • Tran, Phuoc T.;
    • Pavlovich, Christian P.;
    • Deville, Curtiland;
    • Allaf, Mohamad E.;
    • Greco, Stephen C.;
    • Song, Daniel Y.;
    • Bivalacqua, Trinity J.;
    • Han, Misop;
    • Partin, Alan W.;
    • Sartor, A. Oliver;
    • Rowe, Steven P.;
    • Pienta, Kenneth J.
    Publication type:
    Article
    5